Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AE.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.201NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.221NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.410NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.310NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.185NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.258.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.329NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.229NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.342NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.90NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.169NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.53NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.4.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.528NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.175NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.6.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.483NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.181NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.113NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.594NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.328NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.13NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.145NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.547NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.247NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.4.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.205NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.110NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.434NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.4.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.181NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.6.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.37NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.51NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.3.18NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XATNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.24NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.3.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.3.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.85NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.65NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BG.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.61NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.23NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.74NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BM.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used